24
Participants
Start Date
August 17, 2023
Primary Completion Date
June 1, 2025
Study Completion Date
June 1, 2025
Betamethasone Dipropionate Nasal Cream 0.0644%
Betamethasone Dipropionate Nasal Cream 0.0644% is applied topically to the inflamed tissue of the sinus using a pre-filled syringe and applicator under the guidance of an endoscope. Up to 5g on each side of the sinus (10g in total).
Pre-filled syringe and applicator device
Cream is pre-filled to a syringe and applicator device to facilitate the topical application direct to the sinus under endoscopic guidance.
RECRUITING
Oticara Investigational Site, Sydney
RECRUITING
Oticara Investigational Site, Brisbane
RECRUITING
Oticara Investigational Site, Adelaide
RECRUITING
Oticara Investigational Site, Perth
Oticara Australia PTY LTD
INDUSTRY